Subtype
Childhood Glioma
CI-CAN-00002254Explore in graph →
PediatricNon-malignant11 active trials21 evidence items
- NCIt
- C221717
Loading cancer entity…
Subtype
CI-CAN-00002254Explore in graph →
Clinical trials
67 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06666348 | Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK(MIRV) | recruiting | Phase 1 / Phase 2 | 50 | St. Justine's HospitalOTHER | 1 | Aug 11, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 11, 2026source: clinicaltrials